Unknown PHASE1 INTERVENTIONAL 3-arm NCT00311805

Autologous CD34+ Stem Cell Injection for Severe Intermittent Claudication (Leg Pain)

Injection of Autologous CD34-Positive Stem Cells for Neovascularization and Symptom Relief in Patients With Severe Intermittent Claudication

Sponsor: Losordo, Douglas, M.D.

Conditions Peripheral Artery Disease Severe Intermittent Claudication

Interventions Autologous Stem Cells (CD34+)

Updated 7 times since 2017 Last updated: Mar 30, 2015 Started: Apr 30, 2006 Primary completion: Dec 31, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates Peripheral Artery Disease and Severe Intermittent Claudication and is currently ongoing. Losordo, Douglas, M.D. leads this study, which shows 7 recorded versions since 2006 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE1
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE1

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE1
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE1
May 2017 — Jun 2018 [monthly]

Unknown Status PHASE1

Status: Active Not Recruiting → Unknown Status

▶ Show 2 earlier versions

Feb 2017 — May 2017 [monthly]

Active Not Recruiting PHASE1
Jan 2017 — Feb 2017 [monthly]

Active Not Recruiting PHASE1

First recorded

Apr 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Losordo, Douglas, M.D.

Data source: Losordo, Douglas, M.D.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Birmingham, United States
• Chicago, United States